This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Albemarle Supports EPA Efforts To Address PBDEs

Stocks in this article: ALB

BATON ROUGE, La. , July 10, 2012 /PRNewswire/ -- In a letter to Administrator Lisa P. Jackson, Albemarle Corporation (NYSE: ALB) today offered its support of the Environmental Protection Agency's efforts to finalize its proposed actions on Polybrominated diphenyl ethers (PBDEs). Such action will ensure that decaBDE will not be imported into the United States after December 31, 2013.

(Logo:  http://photos.prnewswire.com/prnh/20111129/MM14279LOGO )

In the letter, Dr. David Clary, Albemarle's Chief Sustainability Officer, commented, "Albemarle supports the EPA proposal to amend the PBDE SNUR to designate manufacturing, importing, or processing of decaBDE for any use which is not ongoing after December 31, 2013 as a significant new use.  Further, Albemarle supports the EPA's efforts to promulgate a test rule for PBDEs if it determines that manufacture (including import) or processing of PBDEs has not ceased by December 31, 2013."

Albemarle, in cooperation with the EPA, announced a voluntary phase out of its production of decaBDE in 2009.  The company is on schedule to cease commercial production of decaBDE entirely by the end of 2012 in accordance with its agreement with EPA and will limit commercial sales within the United States in 2013 to only transportation and military applications requiring that additional transition time.  

While many science-based and peer-reviewed studies have shown decaBDE to be safe in its intended use, Albemarle is committed to delivering safe and effective products with increasingly smaller environmental footprints.  The company's proactive innovation has allowed it to bring two polymeric flame retardants to market in the last few years:  GreenArmor and GreenCrest.  These polymeric flame retardants, marketed under the Earthwise portfolio, represent the latest fire safety technology and provide additional certainty about product safety as they can't be absorbed by animal or human cells.  GreenCrest has successfully completed review by EPA's New Chemicals Program and GreenArmor has been submitted for such a review.

About Albemarle Albemarle Corporation, headquartered in Baton Rouge, Louisiana, is a leading global developer, manufacturer, and marketer of highly-engineered specialty chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, automotive/transportation, pharmaceuticals, crop protection, food-safety and custom chemistry services. The Company is committed to global sustainability and is advancing its eco-practices and solutions in its three business segments, Polymer Solutions, Catalysts and Fine Chemistry. Corporate Responsibility Magazine selected Albemarle to its prestigious "100 Best Corporate Citizens" list for 2010 and 2011.  Albemarle employs approximately 4,000 people and serves customers in approximately 100 countries. Albemarle regularly posts information to www.albemarle.com, including notification of events, news, financial performance, investor presentations and webcasts, Regulation G reconciliations, SEC filings, and other information regarding the Company, its businesses and the markets we serve.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding Albemarle Corporation's business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see "Risk Factors" in the Company's Annual Report on Form 10-K.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs